News · 18 November 2026

Wegovy pill sales lift Novo's profit and its outlook

18 November 2026 · DE · Business · Health

Wegovy pill sales lift Novo's profit and its outlook
Picture: BioPharma Dive · BioPharma Dive lead image · unknown

Third-quarter sales rose 4% to $11.9 billion, beating forecasts, and shares rose as much as 6%. Chief executive Mike Doustdar said Novo still has 80% of the market.

Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026